|
|
|
Volumn , Issue , 2004, Pages
|
|
Despite warnings, drug giant took long path to Vioxx recall.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
LACTONE;
ROFECOXIB;
SULFONE;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
DRUG APPROVAL;
DRUG INDUSTRY;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE AND PUBLIC HEALTH;
HEART INFARCTION;
HUMAN;
LEGAL APPROACH;
LEGAL ASPECT;
LEGAL LIABILITY;
MERCK INC.;
POPULAR APPROACH/SOURCE;
POSTMARKETING SURVEILLANCE;
UNITED STATES;
HEALTH CARE AND PUBLIC HEALTH;
LEGAL APPROACH;
MERCK INC.;
POPULAR APPROACH/SOURCE;
DRUG APPROVAL;
DRUG INDUSTRY;
HUMANS;
LACTONES;
LIABILITY, LEGAL;
MYOCARDIAL INFARCTION;
PRODUCT SURVEILLANCE, POSTMARKETING;
SULFONES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 16544373278
PISSN: 03624331
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (23)
|
|
References (0)
|
